Syncona Limited Issue of shares pursuant to incentive scheme (5790S)
15 Julio 2022 - 1:00AM
UK Regulatory
TIDMSYNC
RNS Number : 5790S
Syncona Limited
15 July 2022
Syncona Limited
Issue of shares pursuant to incentive scheme and PDMR
dealings
15 July 2022
Syncona Ltd (the "Company"), a leading healthcare company
focused on founding, building and funding a portfolio of global
leaders in life science, today announces that a total of 2,595,736
new ordinary shares (representing 0.39% of the Company's existing
issued ordinary shares) will be issued in satisfaction of
realisations under the Company's long term incentive scheme. The
new ordinary shares, when issued, will rank pari passu with the
existing issued ordinary shares of the Company. In accordance with
the rules of the incentive scheme, the number of ordinary shares to
be issued has been calculated using the closing mid-market price on
13 July 2022, GBP1.964.
In accordance with the rules of the incentive scheme, ordinary
shares delivered on realisation may not be sold or transferred by
the recipient for a period of one year following the realisation
date.
The issue of shares include the following shares to be issued to
senior members of the Syncona Investment Management Limited (SIML)
leadership team:
Name SIML Title No. of shares to be
issued
Martin Murphy Chief Executive Officer 993,527
-------------------------- --------------------
Chris Hollowood Chief Investment Officer 642,815
-------------------------- --------------------
Application will be made to the Financial Conduct Authority for
the shares to be admitted to the Official List, and to the London
Stock Exchange for the shares to be admitted to trading and it is
expected that dealings will commence in the new ordinary shares on
20 July 2022.
Following admission, the Company will have 669,329,324 ordinary
shares in issue and the total number of voting rights in the
Company will be 669,329,324 . The Company does not hold any
ordinary shares in treasury. This figure may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or
a change in their interests in, the Company under the FCA's
Disclosure and Transparency Rules.
Notification of transactions by Persons Discharging Managerial
Responsibilities ("PDMRs") are set out below.
[ENDS]
Enquiries
Syncona Ltd
Natalie Garland-Collins / Fergus Witt
Tel: +44 (0) 7714 916615
About Syncona
Syncona's purpose is to invest to extend and enhance human life.
We do this by founding and building companies to deliver
transformational treatments to patients in areas of high unmet
need.
Our strategy is to found, build and fund companies around
exceptional science to create a diversified portfolio of 15-20
globally leading healthcare businesses, across development stage
and therapeutic areas, for the benefit of all our stakeholders. We
focus on developing treatments for patients by working in close
partnership with world-class academic founders and management
teams. Our balance sheet underpins our strategy enabling us to take
a long-term view as we look to improve the lives of patients with
no or poor treatment options, build sustainable life science
companies and deliver strong risk-adjusted returns to
shareholders.
Copies of this press release and other corporate information can
be found on the company website at: www.synconaltd.com
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Martin Murphy
--------------------- ----------------------------------------
b) Position / Chief Executive Officer, SIML
status
--------------------- ----------------------------------------
c) Initial notification Initial Notification
/ amendment
--------------------- ----------------------------------------
2. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------
a) Description Ordinary shares
of the financial GG00B8P59C08
instrument
--------------------- ----------------------------------------
b) Nature of Issue of shares pursuant to the Syncona
the transaction long term incentive scheme
--------------------- ----------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBP1.964 993,527
--------------------- ----------------------------------------
d) Aggregated
information
Aggregated N/A
volume
Price
--------------------- ----------------------------------------
e) Date of the 14 July 2022
transaction
--------------------- ----------------------------------------
f) Place of the Outside a trading venue
transaction
--------------------- ----------------------------------------
g) Currency GBP - British Pound
--------------------- ----------------------------------------
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Chris Hollowood
--------------------- ----------------------------------------
b) Position / Chief Investment Officer, SIML
status
--------------------- ----------------------------------------
c) Initial notification Initial Notification
/ amendment
--------------------- ----------------------------------------
2. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------
a) Description Ordinary shares
of the financial GG00B8P59C08
instrument
--------------------- ----------------------------------------
b) Nature of Issue of shares pursuant to the Syncona
the transaction long term incentive scheme
--------------------- ----------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBP1.964 642,815
--------------------- ----------------------------------------
d) Aggregated
information
Aggregated N/A
volume
Price
--------------------- ----------------------------------------
e) Date of the 14 July 2022
transaction
--------------------- ----------------------------------------
f) Place of the Outside a trading venue
transaction
--------------------- ----------------------------------------
g) Currency GBP - British Pound
--------------------- ----------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEUSRORUWUBAUR
(END) Dow Jones Newswires
July 15, 2022 02:00 ET (06:00 GMT)
Syncona (LSE:SYNC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Syncona (LSE:SYNC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
